Bariatric treatments for adult obesity - Institute of Health Economics

More documents

Recommendations

Info

CRD Databases(DARE, HTA & NHS EED)http://nhscrd.york.ac.ukEMBASELicensed Resource (OvidPlatform)2000 –April 8, 20102000 –April 8, 2010(2010 Week13)53. limit 52 to yr="2000 - 2010"54. 5 and 5355. exp "Costs and Cost Analysis"/56. (economic adj1 (evaluat* or analys* or study or studies orassess* or consequence*)).tw.57. (cost-benefit or benefit-cost or cost effectiv* or costutility).tw.58. (cost minimization or cost minimisation or costconsequence* or cost offset*).tw.59. ((cost or costs) adj2 analys*).tw.60. "cost of illness".tw.61. (cost* or economic* or expenditures or fiscal orpharmacoeconomic or spending).ti.62. or/55-6163. 54 and 62422 results# 1 obes* OR superobes* RESTRICT YR 2000 2010# 2 diet:ti OR lifestyle:ti OR exercise:ti OR walking:ti ORbehavioural:ti OR behavioral:ti OR cognitive:ti ORpsychological:ti OR modification:ti# 3 "weight loss" OR "weight reduction" OR "weightmanagement" OR "physical activity"# 4 sibutramine OR orlistat OR "appetite suppressants" OR"antiobesity agents" OR counseling OR "cognitive therapy" OR"behavioral therapy" OR psychotherapy OR counseling OR"patient education"#5 MeSH Bariatric Surgery Explode 1#6 surger*:ti OR "gastric band*":ti OR "gastric bypass":ti OR"lab band*":ti OR LAGB:ti#7 child*:ti NOT adult:ti#8 #2 OR #3 OR #4 OR #5 OR #6#9 #1 AND #7#10 #9 NOT #7#11 cost* OR economic* OR expenditures OR fiscal ORpharmacoeconomic# 12 #11 AND #10145 results1. *obesity/2. *morbid obesity/3. *diabetic obesity/4. *abdominal obesity/5. or/1-46. (superobes* or obes* or bariatric* or weight).ti.7. (unplanned weight or unintended weight or involuntaryweight or antipsychotic* or schizophreni* or bipolar orParkinson* or Alzheimer* or smoking or dementia or bulimi* oranorexi* or urinary incontinence or ui or pelvic floor or asthmaor adhd or attention-deficit or apnea or cancer or colorectal orBariatric treatments for adult obesity 180
gastroesophageal or fatty liver or osteoarthritis or arthritis orcontaceptive* or erectile or urologic* or mood disorders or birthweight or diarrhea or kidney or gallstone*).ti.8. (5 or 6) not 79. exp bariatric surgery/10. exp stomach surgery/11. surgery.ti.12. gastric bypass.ti.13. roux en y.ti.14. biliopancreatic diversion*.ti.15. gastrectom*.ti.16. intragastric balloon*.ti.17. bariatrics/18. weight reduction/19. antiobesity agent/20. exp anorexigenic agent/21. sibutramine/22. sibutramine.tw.23. (reductil or meridia or sibutrex).tw.24. orlistat.tw.25. (xenical or alli or tetrahydrolipstatin).tw.26. diet therapy/27. diet restriction/ or caloric restriction/28. diet therapy/ or diabetic diet/ or low calory diet/ or low fatdiet/29. diet.ti.30. exercise/ or aerobic exercise/ or anaerobic exercise/ oraquatic exercise/31. fitness/32. exercise.ti.33. exp physical activity/34. physical activity.ti.35. yoga/ or pilates/36. lifestyle.ti.37. life style.ti.38. walking.ti.39. behavior therapy/40. cognitive therapy/41. psychotherapy/42. behavior modification/43. group therapy/44. counseling/ or nutritional counseling/45. counseling.ti.46. behavi?ral.ti.47. weight management.ti.48. psychological.ti.Bariatric treatments for adult obesity 181
Page 1 and 2:
Alberta STE ReportBariatric treatme
Page 3 and 4:
Alberta STE ReportBariatric treatme
Page 5 and 6:
EXECUTIVE SUMMARYSocial and System
Page 7 and 8:
Three surgical procedures—adjusta
Page 9:
Costs of Bariatric Surgery and Pote
Page 12 and 13:
Regulatory status .................
Page 14 and 15:
TABLES AND FIGURESSection One: Soci
Page 16 and 17:
ABBREVIATIONSAll abbreviations that
Page 18 and 19:
LYMmMAMDMUHCNANHLBINHSNICENIHNNHNPH
Page 20 and 21:
Bariatric physician: a licensed Doc
Page 22 and 23:
High-density lipoprotein (HDL): a f
Page 24 and 25:
Very-low-calorie diet (VLCD): a die
Page 26 and 27:
Additional Internet searches were c
Page 28 and 29:
This report addresses obesity in ad
Page 30 and 31:
Many systemic factors have been ide
Page 32 and 33:
Severe obesity is associated with d
Page 34 and 35:
eport their height and under-report
Page 36 and 37:
Also using self-reported data from
Page 38 and 39:
An examination of overall obesity d
Page 40 and 41:
Table S.2 presents the associationa
Page 42 and 43:
• have multiple focal points and
Page 45 and 46:
The main problem in any weight mana
Page 47:
food, and a negative body image. As
Page 50 and 51:
directly causes death. 61 To the ex
Page 52 and 53:
The addition of a selected pharmaco
Page 54 and 55:
lack of formal training in nutritio
Page 56 and 57:
slightly more likely to have prescr
Page 58 and 59:
selection criteria, have facilities
Page 60 and 61:
Barriers to using appropriate baria
Page 62 and 63:
Overview of adult obesityOver the p
Page 64 and 65:
the need for regular physical activ
Page 66 and 67:
phenylpropanolamine/25. Sibutramine
Page 68 and 69:
Complianceand AdherenceDemand andut
Page 70 and 71:
Aetna Clinical PolicyBulletinswww.a
Page 72 and 73:
Overweight 123,821 172,971 157,623
Page 74 and 75:
REFERENCES1. 2006 Canadian clinical
Page 76 and 77:
34. Gostin LO. Fast and supersized:
Page 78 and 79:
69. Klarenbach S, Padwal R, Wiebe N
Page 80 and 81:
105. Hill JO, Thompson H, Wyatt H.
Page 82 and 83:
141. Ross R, Bradshaw AJ. The futur
Page 84 and 85:
172. Arkinson J, Ji H, Fallah S, Pe
Page 86 and 87:
This section will address a set of
Page 88 and 89:
dietary therapy is to reduce total
Page 90 and 91:
Additional benefits of exercise ove
Page 92 and 93:
medications that inhibit intestinal
Page 94 and 95:
Rimonabant may be considered for pa
Page 96 and 97:
Long-term complications are specifi
Page 98 and 99:
Devices used for bariatric surgeryH
Page 100 and 101:
Description of the Included Systema
Page 102 and 103:
AEs for sibutramineAs compared to a
Page 104 and 105:
Evidence on Efficacy/EffectivenessW
Page 106 and 107:
Table T.7: Effects of behavioural t
Page 108 and 109:
SurgeryDescription of the included
Page 110 and 111:
follow-up time was 3 years. Results
Page 112 and 113:
group as compared to the VBG group.
Page 114 and 115:
The authors identified many methodo
Page 116 and 117:
The investigators pointed out that
Page 118 and 119:
approximately 3 to 5 kilograms. For
Page 120 and 121:
for studies with a mean age of part
Page 122 and 123:
Examining whether use of any of the
Page 124 and 125:
Evidence from placebo-controlled cl
Page 126 and 127:
colorectal or gastroesophageal or f
Page 128 and 129:
Web of ScienceISI Interface License
Page 130 and 131:
AMA Clinical PracticeGuidelineswww.
Page 132 and 133:
critical appraisal of the included
Page 134 and 135:
APPENDIX T.B: EXCLUDED STUDIESTable
Page 136 and 137:
Padwal R, Li SK, Lau DC. Long-term
Page 138 and 139:
Quality subsection 1: At least MEDL
Page 140 and 141:
Quality subsection 5a:Study quality
Page 142 and 143:
Partially reported: The study types
Page 144 and 145:
Table T.C.1: Results of quality ass
Page 146 and 147:
Table T.C.1: Results of quality ass
Page 148 and 149:
APPENDIX T.D: CHARACTERISTICS OF SY
Page 150 and 151:
Table T.D.1: Characteristics of the
Page 152 and 153:
Table T.D.1: Characteristics of the
Page 154 and 155: Table T.D.2: Characteristics of the
Page 156 and 157: APPENDIX T.E: EVIDENCE TABLE ON SAF
Page 158 and 159: Serious surgical complicationsSurgi
Page 160 and 161: LSGmMAMDNAnssORQoLRCTRDRRRYGBSBPTGV
Page 162 and 163: Table T.F.1-2: Weight loss - Behavi
Page 164 and 165: Table T.F.1-4: Weight loss - Surger
Page 166 and 167: Table T.F.2: Quality of life (QoL)
Page 168 and 169: Curioni & Lourenco 2005 58Cholester
Page 170 and 171: Table T.F.3-3: Risk factors/comorbi
Page 172 and 173: Table T.F.3-5: Long-term effects of
Page 174 and 175: Maciejewski et al., 2005 65Avenell
Page 176 and 177: Table T.G.2: Effects of bariatric s
Page 178 and 179: Table T.G.4: Effects of bariatric s
Page 180 and 181: 18. Cerulli J, Lomaestro BM, Malone
Page 182 and 183: 50. Health Canada Drug Product Data
Page 184 and 185: SECTION THREE: ECONOMIC EVALUATIONC
Page 186 and 187: Definition of bariatric surgical pa
Page 188 and 189: etween surgical interventions, the
Page 190 and 191: concluded that adding orlistat to L
Page 192 and 193: Weight management program (WMP) ver
Page 194 and 195: groups. Compared with standard care
Page 196 and 197: Results from Analysis of Provincial
Page 198 and 199: DiscussionThe objectives of the eco
Page 200 and 201: surgical suites, and so on. The bud
Page 202 and 203: APPENDIX E.A: LITERATURE SEARCH SUM
Page 206 and 207: Web of ScienceISI Interface License
Page 208 and 209: NEOS Librarywww.library.ualberta.ca
Page 210 and 211: Table E.A.2: Evidence table of revi
Page 212 and 213: ResultHealth outcomesCostsMarginal
Page 214 and 215: CostsMarginal analysisThe cost anal
Page 216 and 217: Time Horizon/discount rateCurrency/
Page 218 and 219: Objectivestudy perspective: society
Page 224 and 225: S4Economic burden of obesityMean co
Page 226 and 227: 15. Lacey LA, Wolf A, O'shea D, Ern
Page 228 and 229: Author Contribution StatementsPaula
show all

Bariatric treatments for adult obesity - Institute of Health Economics

Create successful ePaper yourself

Delete template?

Save as template?